Literature DB >> 7114145

Clinical manifestations and radiologic findings in craniopharyngiomas in adults.

T B Crane, R D Yee, R S Hepler, J M Hallinan.   

Abstract

The clinical and histopathologic findings in two adults with craniopharyngioma emphasized the wide age range and diverse initial manifestations of this tumor. A retrospective clinical review of 49 additional patients substantiated these points and disclosed that over 40% were initially examined by ophthalmologists. The initial manifestations fell into four broad categories: (1) visual system abnormalities (77% of the cases), (2) headache (67%), (3) endocrinologic abnormalities (57%), and (4) mental status abnormalities (19%). The frequency of these manifestations varied slightly among different age groups. The radiologic features in the two patients described (a 75-year-old man and a 38-year-old woman) included a distinct appearance on computed tomographic scans. These craniopharyngioma were not calcified and were isodense without contrast but enhanced densely and uniformly with contrast, simulating an aneurysm of the circle of Willis.

Entities:  

Mesh:

Year:  1982        PMID: 7114145     DOI: 10.1016/0002-9394(82)90079-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  SUPRASELLAR PAPILLARY SQUAMOUS EPITHELIOMA (PAPILLARY CRANIOPHARYNGIOMA).

Authors:  T Chatterjee; Sangeeta Desai; R Lakhtakia; S S Gill; S Satyanarayana
Journal:  Med J Armed Forces India       Date:  2017-06-10

Review 2.  Giant cystic craniopharyngiomas.

Authors:  S C Young; R A Zimmerman; M A Nowell; L T Bilaniuk; D B Hackney; R I Grossman; H I Goldberg
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

3.  Acute presentation of craniopharyngioma in children and adults in a Danish national cohort.

Authors:  E H Nielsen; J O Jørgensen; P Bjerre; M Andersen; C Andersen; U Feldt-Rasmussen; L Poulsgaard; L Ø Kristensen; J Astrup; J Jørgensen; P Laurberg
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.